Nexalin Technology, Inc. Marketing and Advertising Expense
Nexalin Technology, Inc. (NXL) reported Marketing and Advertising Expense of $2.30 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:MarketingAndAdvertisingExpense · last filed 2024-05-10
- Nexalin Technology, Inc. marketing and advertising expense for the quarter ending 2024-03-31 was $2.30K, a 18.21% decline year-over-year.
- Nexalin Technology, Inc. marketing and advertising expense for the quarter ending 2023-03-31 was $2.82K.
- Nexalin Technology, Inc. marketing and advertising expense for the quarter ending 2022-12-31 was $2.80K, a 72.01% decline year-over-year.
- Nexalin Technology, Inc. marketing and advertising expense for the quarter ending 2022-09-30 was $12.44K, a 246.19% increase year-over-year.
- Nexalin Technology, Inc. marketing and advertising expense for fiscal 2023 was $11.21K, a 46.98% decline from fiscal 2022.
- Nexalin Technology, Inc. marketing and advertising expense for fiscal 2022 was $21.15K, a 40.40% decline from fiscal 2021.
- Nexalin Technology, Inc. marketing and advertising expense for fiscal 2021 was $35.49K.
| Period end | Marketing and Advertising Expense 3 month | Marketing and Advertising Expense 6 month | Marketing and Advertising Expense 9 month | Marketing and Advertising Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $2.30K 10-Q · filed 2024-05-10 | |||
| 2023-12-31 | $11.21K 10-K · filed 2024-03-27 | |||
| 2023-03-31 | $2.82K 10-Q · filed 2024-05-10 | $5.62K derived: sum of 2 quarters · filed 2024-05-10 | $18.06K derived: sum of 3 quarters · filed 2024-05-10 | |
| 2022-12-31 | $2.80K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $15.24K derived: sum of 2 quarters · filed 2024-03-27 | $21.15K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $12.44K 10-Q · filed 2022-11-10 | $18.34K 10-Q · filed 2022-11-10 | ||
| 2021-12-31 | $10.02K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $13.61K derived: sum of 2 quarters · filed 2023-03-27 | $35.49K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $3.59K 10-Q · filed 2022-11-10 | $25.47K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |